Effect of long-term acupoint application on the regulation of persistent inflammation in allergic rhinitis:a randomized controlled preliminary study

Phase 1

• Conditions: allergic rhinitis(AR)

• Registration Number: ITMCTR2200006053
• Lead Sponsor: Guangdong Provincial Hospital of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Meet the Chinese and western diagnostic criteria of AR, Chinese Medicine syndrome differentiation is deficiency syndrome (Lung, Spleen or Kidney deficiency, two or more aforementioned organs dificiency).
2) 18 to 65 years old, no gender limited.
3) Participants need informed consent and volunteer to participate the study.
4) Be able to complete relevant records such as case report form and cooperate with follow-up and / or waiting as required.

Exclusion Criteria

1) Participants who have suffered rhinitis (cold), vasomotor rhinitis, autonomic rhinitis, eosinophilic non-allergic rhinitis, allergic sinusitis.
2) Participants who are allergic to adhesive tape.
3) Participants who have difficult to heal local skin lesions such as burns, eczema, ulcers and frostbite.
4) Pregnant women, if they are found to be pregnant during the study, suspend the test; women's menstruation is suspended (it can be subsidized after menstruation, but the date of application should be indicated).
5) Participants who can not fully cooperate with the experimenters and investigators,due to mental or behavioral disorders.
6) Participants who are easy to lose follow-up due to frequent changes in working environment and other reasons.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total nasal symptom score;

Secondary Outcome Measures

Name	Time	Method
Interleukin-33;Visual analogue scale;Interleukin-4;Interleukin-17;Eosinophil cationic protein;The standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire;Interleukin-10;Interferon-?;Days of attack per week;